1. Optimal Dosing Frequency of Pegylated Interferon Alfa-2b Monotherapy for Chronic Hepatitis C Virus Infection 
Yoav Lurie, Regine Rouzier-Panis, George J.M. Webster, Geoffrey M. Dusheiko, Mark Laughlin, Mary L. Jackson, Ran Oren 
Clinical Gastroenterology and Hepatology 
Volume 3, Issue 6, Pages (June 2005)
DOI: /S (04)
Copyright © 2005 American Gastroenterological Association Terms and Conditions

2. Figure 1
Effect of PEG-IFN-alfa2b dosage on HCV-RNA clearance at week 12. Bars are mean values with standard error (*#x002A;P < .05 vs IFN-alfa2b). BIW, 2 times/wk; QW, 1 time/wk; TIW, 3 times/wk.
Clinical Gastroenterology and Hepatology 2005 3, DOI: ( /S (04) )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

3. Figure 2
Decrease in absolute neutrophil count (109 cells/L) by dose regimen, from treatment initiation through week 12. BIW, 2 times/wk; QW, 1 time/wk; TIW, 3 times/wk.
Clinical Gastroenterology and Hepatology 2005 3, DOI: ( /S (04) )
Copyright © 2005 American Gastroenterological Association Terms and Conditions